Women's decision-making regarding medication use in pregnancy for anxiety and/or depression

Journal of Advanced Nursing

Volumn 69, Issue 11, 2013, Pages 2470-2480

  Stepanuk, Kathleen M ^a   Fisher, Kathleen M ^a   Wittmann Price, Ruth ^b   Posmontier, Bobbie ^a   Bhattacharya, Anand ^c  

^a DREXEL UNIVERSITY   (United States)

^b FRANCIS MARION UNIVERSITY   (United States)

^c Francis Marion University ^*  (United States)

Author keywords

Anxiety; Depression; Emancipated decision making; Medication use; Nurses; Pregnancy; Satisfaction

Indexed keywords

PSYCHOTROPIC AGENT;

ADOLESCENT; ADULT; ANXIETY; ANXIETY DISORDER; ARTICLE; ATTITUDE TO HEALTH; CROSS-SECTIONAL STUDY; DECISION MAKING; DEPRESSION; EMANCIPATED DECISION-MAKING; FEMALE; HUMAN; MEDICATION USE; MIDDLE AGED; NURSE; PATIENT SATISFACTION; PREGNANCY; PREGNANCY COMPLICATION; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; SATISFACTION; YOUNG ADULT;

ANXIETY; DEPRESSION; EMANCIPATED DECISION-MAKING; MEDICATION USE; NURSES; PREGNANCY; SATISFACTION;

ADOLESCENT; ADULT; ANXIETY DISORDERS; CROSS-SECTIONAL STUDIES; DECISION MAKING; DEPRESSIVE DISORDER; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MIDDLE AGED; PATIENT SATISFACTION; PREGNANCY; PREGNANCY COMPLICATIONS; PSYCHOTROPIC DRUGS; QUESTIONNAIRES; YOUNG ADULT;

EID: 84885179106     PISSN: 03092402     EISSN: 13652648     Source Type: Journal    
DOI: 10.1111/jan.12122     Document Type: Article

References (44)

1. Allison S.K. (2004) Psychotropic medication in pregnancy: ethical aspects and clinical management. Journal of Perinatal and Neonatal Nursing 18(3), 194-205.
2. Alwan S., Reefhuis J., Rasmussen S.A., Olney R.S. & Friedman J.M. (2007) Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects. New England Journal of Medicine 356(26), 2684-2692.
3. Andersson L., Sundstrom-Poromaa I., Wulff M., Astrom M. & Bixo M. (2006) Depression and anxiety during pregnancy and six months postpartum: a follow-up study. Acta Obstetrics and Gynecology Scandinavia 85(8), 937-944.
4. Armstrong C. (2008) ACOG Guidelines on psychiatric medication use during pregnancy and lactation. American Family Physician 78(6), 772.
5. Baggley A., Navioz Y., Maltepe C., Koren G. & Einarson A. (2004) Determinants of women's decision making on whether to treat nausea and vomiting of pregnancy pharmacologically. Journal of Midwifery and Womens Health 49(4), 350-354.
6. Bennett H.A., Einarson A., Taddio A., Koren G. & Einarson T.R. (2004) Prevalence of depression during pregnancy: systematic review. Obstetrics and Gynecology 103(4), 698-709.
7. Bilszta J.L., Tsuchiya S., Han K., Buist A.E. & Einarson A. (2011) Primary care physician's attitudes and practices regarding antidepressant use during pregnancy: a survey of two countries. Archives of Women's Mental Health 14(1), 71-75.
8. Bonari L., Koren G., Einarson T.R., Jasper J.D., Taddio A. & Einarson A. (2005) Use of antidepressants by pregnant women: evaluation of perception of risk, efficacy of evidence based counseling and determinants of decision making. Archives of Womens Mental Health 8(4), 214-220.
9. Chambers C.D., Johnson K.A., Dick L.M., Felix R.J. & Jones K.L. (1996) Birth outcomes in pregnant women taking fluoxetine. New England Journal of Medicine 335(14), 1010-1015.
10. Chambers C.D., Polifka J.E. & Friedman J.M. (2008) Drug safety in pregnant women and their babies: ignorance not bliss. Clinical Pharmacology and Therapeutics 83(1), 181-183.
11. Chung T.K., Lau T.K., Yip A.S., Chiu H.F. & Lee D.T. (2001) Antepartum depressive symptomatology is associated with adverse obstetric and neonatal outcomes. Psychosomatic Medicine 63(5), 830-834.
12. Cohen L.S., Altshuler L.L., Harlow B.L., Nonacs R., Newport D.J., Viguera A.C., Suri R., Burt V.K., Hendrick V., Reminick A.M., Loughead A., Vitonis A.F. & Stowe Z.N. (2006) Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. The Journal of the American Medical Association 295(5), 499-507.
13. Diaz-Caneja A. & Johnson S. (2004) The views and experiences of severely mentally ill mothers-a qualitative study. Social Psychiatry and Psychiatric Epidemiology 39(6), 472-482.
14. Einarson A. (2005) Abrupt discontinuation of psychotropic drugs following confirmation of pregnancy: a risky practice. Journal of Obstetrics and Gynaecology Canada 27(11), 1019-1022.
15. Faisal-Cury A. & Rossi Menezes P. (2007) Prevalence of anxiety and depression during pregnancy in a private setting sample. Archives of Women's Mental Health 10(1), 25-32.
16. Gentile S. (2005) The safety of newer antidepressants in pregnancy and breastfeeding. Drug Safety 28(2), 137-152.
17. Heron J., O'Connor T.G., Evans J., Golding J. & Glover V. (2004) The course of anxiety and depression through pregnancy and the postpartum in a community sample. Journal of Affective Disorders 80(1), 65-73.
18. Holmes-Rovner M., Kroll J., Schmitt N., Rovner D.R., Breer M.L., Rothert M.L., Padonu G. & Talarczyk G. (1996) Patient satisfaction with health care decisions: the satisfaction with decision scale. Medical Decision Making 16(1), 58-64.
19. Jasper J.D., Goel R., Einarson A., Gallo M. & Koren G. (2001) Effects of framing on teratogenic risk perception in pregnant women. Lancet 358(9289), 1237-1238.
20. Kallen B.A. & Otterblad Olausson P. (2007) Maternal use of selective serotonin reuptake inhibitors in early pregnancy and infant congenital malformations. Birth Defects Research. Part A Clinical and Molecular Teratology 79(4), 301-308.
21. Kelly C.M. & Jorm A.F. (2007) Stigma and mood disorders. Current Opinions in Psychiatry 20, 13-16.
22. Krumm S. & Becker T. (2006) Subjective views of motherhood in women with mental illness - a sociological perspective. Journal of Mental Health 15(4), 449-460.
23. Lee A.M., Lam S.K., Sze Mun Lau S.M., Chong C.S., Chui H.W. & Fong D.Y. (2007) Prevalence, course and risk factors for antenatal anxiety and depression. Obstetrics and Gynecology 110(5), 1102-1112.
24. Lorenzo L., Byers B. & Einarson A. (2011) Antidepressant use in pregnancy. Expert Opinion Drug Safety 10(6), 883-889. Downloaded from informahealth.com.
25. Louik C., Lin A.E., Werler M.M., Hernandez-Diaz S. & Mitchell A.A. (2007) First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects. New England Journal of Medicine 356(26), 2675-2683.
26. Miller L.J. (2009) Ethical issues in perinatal mental health. Psychiatric Clinics of North America 32(2), 259-270.
27. Mitchell A.A., Gilboa S.M., Werler M.M., Kelley K.E., Louik C. & Hernandez-Diaz S. (2011) Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008. American Journal of Obstetrics and Gynecology 205(1), 51 e1-51 e8.
28. O'Connor A.M., Drake E.R., Fiset V., Graham I.D., Laupacis A. & Tugwell P. (1999) The Ottawa patient decision aids. Effective Clinical Practice 2(4), 163-170.
29. O'Mahen H.A., Henshaw E., Jones J.M. & Flynn H.A. (2011) Stigma and depression during pregnancy: does race matter? The Journal of Nerve and Mental Disease 199(4), 257-262.
30. Orr S.T., Blazer D.G., James S.A. & Reiter J.P. (2007) Depressive symptoms and indicators of maternal health status during pregnancy. Journal of Women's Health (Larchmt) 16(4), 535-542.
31. Patel S.R. & Wisner K.L. (2011) Decision making for depression treatment during pregnancy and the postpartum period. Depress Anxiety 28(7), 589-595.
32. Pole M., Einarson A., Pairaudeau N., Einarson T. & Koren G. (2000) Drug labeling and risk perceptions of teratogenicity: a survey of pregnant Canadian women and their health professionals. Journal of Clinical Pharmacology 40(6), 573-577.
33. Russell C.W., Boggs D.A., Palmer J.R. & Rosenberg L. (2010) Use of a web-based questionnaire in the Black Women's Health Study. American Journal of Epidemiology 172(11), 1286-1291.
34. Sandelowski M., Lambe C. & Barroso J. (2004) Stigma in HIV-positive women. Journal of Nursing Scholarship 36(2), 122-128.
35. Sanz E., Gomez-Lopez T. & Martinez-Quintas M.J. (2001) Perception of teratogenic risk of common medicines. European Journal of Obstetrics, Gynecology and Reproductive Biology 95(1), 127-131.
36. Scott-Johnson P.E., Gross S.M. & Browne D.C. (2010) Web-based data collection: an effective strategy for increasing African Americans' participation in health-related research. Ethnicity and Disease 20(1 Suppl 1), S1-201-S1-206.
37. Sjostrom K., Valentin L., Thelin T. & Marsal K. (1997) Maternal anxiety in late pregnancy and fetal hemodynamics. European Journal of Obstetrics, Gynecology and Reproductive Biology 74(2), 149-155.
38. van Trigt A.M., Waardenburg C.M., Haaijer-Ruskamp F.M. & de Jong-van den Berg L.T. (1994) Questions about drugs: how do pregnant women solve them? Pharmarcy World and Science 16(6), 254-259.
39. Wills C.E. & Holmes-Rovner M. (2006) Integrating decision making and mental health interventions research: research directions. Clinical Psychology 13(1), 9-25.
40. Wittmann-Price R.A. (2004) Emancipation in decision-making in women's health care. Journal of Advanced Nursing 47(4), 437-445.
41. Wittmann-Price R.A. (2006) Exploring the subconcepts of the Wittmann-Price theory of emancipated decision-making in women's health care. Journal of Nursing Scholarship 38(4), 377-382.
42. Wittmann-Price R.A. & Bhattacharya A. (2008) Reexploring the subconcepts of the Wittmann-Price theory of emancipated decision making in women's healthcare. ANS Advance Nursing Science 31(3), 225-236.
43. Wittmann-Price R.A., Fliszar R. & Bhattacharya A. (2011) Elective cesarean births: are women making an emancipated decision? Applied Nursing Science 24(3), 147-152.
44. Yonkers K.A., Wisner K.L., Stewart D.E., Oberlander T.F., Dell D.L., Stotland N., Ramin S., Chaudron L. & Lockwood C. (2009) The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists. Obstetrics and Gynecology 114(3), 703-713.